ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Hot Features

Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.

DYN Dyne Therapeutics Inc

26,00
0,17 (0,66%)
02 Mai 2024 - Fechado
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Dyne Therapeutics Inc DYN NASDAQ Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
0,17 0,66% 26,00 18:30:00
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
26,34 24,79 27,11 26,00 25,83
mais cotações »

Notícias Recentes

Data Hora Fonte Título
02/05/202417:10GLOBEDyne Therapeutics Reports First Quarter 2024 Financial..
27/03/202417:05GLOBEDyne Therapeutics Reports Inducement Grant Under Nasdaq..
27/03/202409:30GLOBEDyne Therapeutics to Present at the Cantor Virtual Muscular..
25/03/202408:30GLOBEDyne Therapeutics Announces CEO Transition
13/03/202408:30GLOBEDyne Therapeutics to Present at Stifel 2024 Virtual CNS Days
05/03/202409:30GLOBEDyne Therapeutics Reports Fourth Quarter and Full Year 2023..
14/02/202418:15GLOBEDyne Therapeutics Announces Upcoming Presentations on..
01/02/202409:30GLOBEDyne Therapeutics to Present at February Investor..
11/01/202418:05GLOBEDyne Therapeutics Announces Closing of Public Offering of..
05/01/202409:30GLOBEDyne Therapeutics to Present at 42nd Annual J.P. Morgan..
05/01/202400:46GLOBEDyne Therapeutics Announces Pricing of $300 Million Public..
03/01/202418:25GLOBEDyne Therapeutics Announces Proposed Public Offering of..
03/01/202408:30GLOBEDyne Therapeutics Announces Positive Initial Clinical Data..
02/01/202418:05GLOBEDyne Therapeutics to Host Virtual Event Tomorrow, January 3..
07/11/202309:30GLOBEDyne Therapeutics to Present at November Investor..
30/10/202308:30GLOBEDyne Therapeutics Reports Third Quarter 2023 Financial..
28/09/202308:30GLOBEDyne Therapeutics to Present at October Investor Conferences
20/09/202317:51DJNDyne Therapeutics Gets New FDA Orphan Drug Designation
20/09/202317:05GLOBEDyne Therapeutics Receives FDA Orphan Drug Designation for..
05/09/202308:30GLOBEDyne Therapeutics to Present at Morgan Stanley 21st Annual..
03/08/202308:30GLOBEDyne Therapeutics Reports Second Quarter 2023 Financial..
01/06/202308:30GLOBEDyne Therapeutics to Present at Jefferies Healthcare..
25/05/202308:30GLOBEDyne Therapeutics Receives European Medicines Agency (EMA)..
17/05/202308:30GLOBEDyne Therapeutics’ Preclinical Data Demonstrating FORCE™..
11/05/202308:30GLOBEDyne Therapeutics Reports First Quarter 2023 Financial..

Seu Histórico Recente

Delayed Upgrade Clock